{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06190717",
            "orgStudyIdInfo": {
                "id": "MAFASA-2023"
            },
            "organization": {
                "fullName": "Sonavex, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial",
            "officialTitle": "Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial",
            "acronym": "MAFASA",
            "therapeuticArea": [
                "Endocrinology",
                "Nephrology and Renal Diseases"
            ],
            "study": "maturation-of-arteriovenous-fistula-with-automated-sonography-assessments-trial"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-02-21",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-02-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-02-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-12-19",
            "studyFirstSubmitQcDate": "2023-12-19",
            "studyFirstPostDateStruct": {
                "date": "2024-01-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-23",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Sonavex, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "This is a prospective, multi-center, two-arm, randomized trial to quantify the performance of the EchoMark\u00ae/EchoSure\u00ae System for AVF diagnostic ultrasound when used under a protocol of biweekly use for assessing fistula maturation and reducing time to Clinical Maturation."
        },
        "conditionsModule": {
            "conditions": [
                "Diabetes",
                "End Stage Renal Disease"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 304,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Diagnostic Arm",
                    "type": "EXPERIMENTAL",
                    "description": "All subjects will have the EchoMark implanted. Subjects will be assessed every 2 weeks (+/- 1 week) (but no more frequently than weekly) with the EchoSure system until fistula maturation occurs and/or permanent access use is achieved.",
                    "interventionNames": [
                        "Device: EchoMark/EchoSure"
                    ]
                },
                {
                    "label": "Standard of Care",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Subjects will be evaluated per KDOQI guidelines (with physical examination at approximately 2 weeks (+/- 1 week) and between 4 and 6 weeks (+/- 1 week)). If evaluation yields abnormal findings, subjects will receive a Duplex ultrasound assessment (DUS). All SOC Arm subjects will be followed per the institution's standard of care until fistula maturation occurs and/or permanent access use is achieved but no more frequently than once per month.",
                    "interventionNames": [
                        "Procedure: Standard of Care"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "EchoMark/EchoSure",
                    "description": "Subjects assigned to the Diagnostic Arm will have the EchoMark implanted at the time of AVF creation. The subject will return every 2 weeks for a follow-up assessment to include an EchoSure scan until fistula maturation and/or permanent access use is achieved. The EchoSure scans are to be reviewed by the investigator(s) or delegated study staff and aid in the determination when a further assessment, including a physical exam, is required to determine cannulation clearance or if an intervention(s) may be required to prevent failure of fistula maturation. All physical exams will include assessing the fistula for bruit and thrill. The subject's medical history will be reviewed at each visit and will include all interventions, cannulation attempts, and adverse event reporting.",
                    "armGroupLabels": [
                        "Diagnostic Arm"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Standard of Care",
                    "description": "Subjects are assessed using standard of care per KDOQI guidelines, which includes a physical exam at the 2-week follow-up visit and at the 4-6-week follow-up visit. All follow-up visits will include an assessment of adverse events and medical history review to include all interventions, cannulation attempts, and laboratory results. If evaluation yields an abnormal finding, subjects will undergo a Duplex ultrasound assessment and treatment under the institution's standard of care. All SOC Arm subjects will be followed per the institution's standard of care until fistula maturation occurs and/or permanent access use is achieved but no more frequently than once per month.",
                    "armGroupLabels": [
                        "Standard of Care"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Primary Safety Endpoint",
                    "description": "Freedom from the following through 6 months as adjudicated by the CEC:\n\n1. Clinically significant misplacement or migration of the EchoMark implant.\n2. Vessel or tissue injury caused by the EchoMark implant procedure of the implant over time, requiring surgical intervention.\n3. Infection of tissues surrounding the EchoMark implant requiring IV/\n4. Complication requiring explantation of the EchoMark implant.",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Primary Effectiveness Endpoint",
                    "description": "Time to clinical maturation",
                    "timeFrame": "6 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Difference between EchoSure and Duplex Flow Measurements",
                    "description": "Difference between log10-transformed EchoSure and Duplex flow measurements of blood flow for assessment of measurement agreement in the diagnostic arm.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "EchoSure Depth Comparison",
                    "description": "Difference between EchoSure and CoreLab measurements of depth for assessment of measurement agreement in the diagnostic arm.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "EchoSure Diameter Comparison",
                    "description": "Difference between EchoSure and CoreLab measurement of diameter for assessment of measurement agreement in the diagnostic arm.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "EchoMark/EchoSure System Technical Success",
                    "description": "Technical Success defined as the successful implantation of the EchoMark implant and the ability to complete each scan to determine the blood flow, diameter, and depth measurements at the EchoMark using the EchoSure diagnostic ultrasound system from baseline to Clinical Maturation, fistula failure, or 4 months, whichever is sooner.",
                    "timeFrame": "4 Months"
                },
                {
                    "measure": "CVC Removal",
                    "description": "Time to CVC removal by subject group",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Rate of Hospitalization",
                    "description": "Rate of hospitalization(s) by subject group from baseline to Clinical Maturation.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "AV Fistula Maturation Rate",
                    "description": "Percent of AVFs created that mature by 180 days by subject group.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Total Cost of Care",
                    "description": "Total cost of care, defined by National average Medicare payment rate (facility and professional fees) for procedures and care provided to subject by subject group from baseline to Clinical Maturation.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Freedom from Events through 30 and 90 Days",
                    "description": "Freedom from the following through 30 and 90 days from the baseline procedure as adjudicated by the CEC:\n\n1. Clinically significant misplacement or migration of the EchoMark implant.\n2. Vessel or tissue injury caused by the EchoMark implant procedure of the implant over time, requiring surgical intervention.\n3. Infection of tissues surrounding the EchoMark implant requiring IV antibiotic treatment.\n4. Complication requiring explantation of the EchoMark implant.",
                    "timeFrame": "30 Days and 90 Days"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Hierarchical Composite 1",
                    "description": "Hierarchical composite of the DIAG arm and SOC arm comparing occurrences of:\n\nFistula creation success.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Hierarchical Composite 2",
                    "description": "Hierarchical composite of the DIAG arm and SOC arm comparing occurrences of:\n\nAlive through 180 days.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Hierarchical Composite 3",
                    "description": "Hierarchical composite of the DIAG arm and SOC arm comparing occurrences of:\n\nFreedom from SAE with 180 days (severity as a tie-breaker for SAEs with matching adverse event term)",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Hierarchical Composite 4",
                    "description": "Hierarchical composite of the DIAG arm and SOC arm comparing occurrences of:\n\nEarlier time to AV fistula Clinical Maturation with 180 days.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Comparison of Composite and Stratified MAE Rates",
                    "description": "Comparison of composite and stratified MAE rates for both subject groups at 6 months and end of study. MAEs are adjudicated by the CEC and defined as any of the following:\n\n1. Clinically significant misplacement or migration of the EchoMark implant.\n2. Vessel or tissue injury caused by the EchoMark implant procedure or the implant over time, requiring surgical intervention.\n3. Complication requiring explantation of the EchoMark implant.\n4. Clinically significant surgical complications (seroma, edema, hematoma, bleeding), excluding expected resorption response visible as hypoechoic region on B-mode ultrasound.\n5. Infection requiring IV antibiotic treatment. Pseudoaneurysm.\n6. Thrombosis of the AVF circuit that requires an intervention (surgical or endovascular).\n7. Steal Syndrome.",
                    "timeFrame": "6 Months and 12 Months"
                },
                {
                    "measure": "Comparision of Implant and Procedure Related Adverse Events",
                    "description": "Comparison of all stratified implant and procedure related AE (as adjudicated by the CEC) rates between subject groups at 6 months and end of study.",
                    "timeFrame": "6 Months and 12 Months"
                },
                {
                    "measure": "Clinical Maturation",
                    "description": "Percent of subjects that have reached Clinical Maturation (as adjudicated by the CEC) for each subject group at 90 days, 120 day, 150 days, and 180 days.",
                    "timeFrame": "3 Months, 4 Months, 5 Months, and 6 Months"
                },
                {
                    "measure": "Cannulation Complication Rates",
                    "description": "Comparison of composite and stratified cannulation complication (as adjudicated by the CEC) rates between subject groups for the following AEs:\n\n1. Infection due to cannulation.\n2. Thrombosis due to hematoma.\n3. Any other AE determined by the CEC to be cannulation related.",
                    "timeFrame": "12 Months"
                },
                {
                    "measure": "Time to Clinical Maturation for Procedure and Device Related Events",
                    "description": "Distribution of time to Clinical Maturation for both groups for each of the following procedure and device related categories presented as violin/box plots:\n\n1. Clinically significant misplacement or migration of the EchoMark implant.\n2. Vessel or tissue injury caused by the EchoMark implant procedure or the implant over time, requiring surgical intervention.\n3. Clinically significant surgical complications (seroma, edema, hematoma, bleeding), excluding expected resorption response visible as hypoechoic region on B-mode ultrasound.\n4. Infection requiring IV antibiotic treatment.\n5. Pseudoaneurysm.\n6. Thrombosis of AVF circuit requiring an intervention (surgical or endovascular).\n7. Steal Syndrome.\n8. No SAE.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Primary Functional Patency",
                    "description": "Primary functional patency at 6 months (as adjudicated by the CEC) defined as freedom from intervention on the AVF after maturation.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Secondary Function Patency",
                    "description": "Secondary functional patency at 6 months (as adjudicated by the CEC) is defined as freedom from abandonment of the AVF after maturation.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Time to Clinical Maturation",
                    "description": "Time to Clinical Maturation (as adjudicated by the CEC) defined as the time from initial fistula creation to Clinical Maturation.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Time to Clinical Maturation for Each Fistula",
                    "description": "Time to Clinical Maturation (as adjudicated by the CEC) for each new fistula defined as the time from new fistula creation to Clinical Maturation.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Technical Success Cannulation Scans",
                    "description": "Rate of cannulation zone technical success rate defined as the ability to complete each scan to determine the diameter, and depth measurements at the proximal, mid, and distal segments of the fistula using the EchoSure diagnostic ultrasound system from the 2-week follow-up to Clinical Maturation, or 4 months, whichever is sooner.",
                    "timeFrame": "4 Months"
                },
                {
                    "measure": "EchoSure Diameter and Depth Comparison in Cannulation Zone",
                    "description": "Agreement of EchoSure diameter and depth results from the cannulation zone at the 6-week follow-up compared to the CoreLab measured diameter and depth results in the DIAG arm.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Intervention to Assist Maturation Rate",
                    "description": "Surgical or Endovascular Interventions to Assist Maturation defined as the difference between groups in the proportion of subjects with surgical or endovascular interventions to assist maturation.",
                    "timeFrame": "6 Months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Males or non-pregnant, non-breastfeeding females \u2265 18 years of age but \\< 85 years of age at the time of informed consent.\n* Subject is able and willing to provide written informed consent prior to receiving any non-standard of care, protocol specific procedures.\n* Subject is willing and capable of complying with all required follow-up visits.\n* Subject and/or Care Team agree that the distance and transportation resources from the patient's home to the clinic are reasonable for study participation and compliance.\n* Subject has an estimated life expectancy \\> 18 months.\n* Subject is ambulatory (cane or walker are acceptable).\n* CKD Stage 5 (eGFR less than 10) or ESRD subjects presenting for upper arm autologous arteriovenous fistula creation that is not transposed for hemodialysis access.\n* Subjects who are currently on dialysis through a CVC or who imminently require dialysis (GFR \\<10).\n* Vein diameter \u2265 2.5 mm at the antecubital fossa per vein mapping.\n* Artery diameter \u2265 2.5 mm per vein mapping.\n* Subject is not participating in another investigational clinical trial that has not met its primary end point. Participation in post-market registry is acceptable.\n\nExclusion Criteria:\n\n* CKD Stage 1-4 or subjects that do not require upper arm autologous arteriovenous fistula creation for hemodialysis access.\n* Subject has history of Steal Syndrome.\n* Subject who is immunocompromised or immunosuppressed.\n* Subject has had three previous failed AV fistulae for hemodialysis access.\n* Subjects expecting to undergo major surgery within 60 days from the EchoMark implantation.\n* Known or suspected active infection on the day of the index procedure.\n* Subjects who had infection(s) in the 30-day window prior to EchoMark placement to reduce the likelihood of partially treated infections that can seed the device and fistula.\n* Subjects with diagnosed bleeding disorder, thrombocytopenia (platelet count \\<50,000), hypercoagulability, and history of recurrent deep vein thrombosis not related to AV access.\n* Subjects with active malignancy.\n* Subjects with a history of poor compliance with the dialysis protocol.\n* Subjects with a known or suspected allergy to any of the device materials.\n* Subjects with an existing fistula or graft.\n* Subjects who are anticipated to convert to peritoneal dialysis or undergo a transplant within 6 months.\n* Subjects who are pregnant, planning on becoming pregnant, or are breast feeding.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "84 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Katy Feeny",
                    "role": "CONTACT",
                    "phone": "443-862-2024",
                    "email": "kfeeny@sonavex.com"
                }
            ],
            "locations": [
                {
                    "facility": "Trinity Research Group",
                    "status": "RECRUITING",
                    "city": "Dothan",
                    "state": "Alabama",
                    "zip": "36301",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "E Ivey",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Jason Beaver, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 31.22323,
                        "lon": -85.39049
                    }
                },
                {
                    "facility": "Southwest Kidney Institute",
                    "status": "RECRUITING",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85004",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "J Rodriguez",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Umar Waheed, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "Capital Medical Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Pennington",
                    "state": "New Jersey",
                    "zip": "08534",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "L Gant",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Christine Lotto, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.32844,
                        "lon": -74.79072
                    }
                },
                {
                    "facility": "Prisma Health",
                    "status": "RECRUITING",
                    "city": "Greenville",
                    "state": "South Carolina",
                    "zip": "29605",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "M Salle",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Sagar Gandhi, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.85262,
                        "lon": -82.39401
                    }
                },
                {
                    "facility": "Medical University of South Carolina Health Orangeburg",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Orangeburg",
                    "state": "South Carolina",
                    "zip": "29118",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "V Anderson",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Mark London, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.49182,
                        "lon": -80.85565
                    }
                },
                {
                    "facility": "Fresenius Vascular Care Memphis MSO",
                    "status": "RECRUITING",
                    "city": "Memphis",
                    "state": "Tennessee",
                    "zip": "38115",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "M Sanford",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Eric Gardner, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.14953,
                        "lon": -90.04898
                    }
                },
                {
                    "facility": "Physicians Care of Virginia",
                    "status": "RECRUITING",
                    "city": "Roanoke",
                    "state": "Virginia",
                    "zip": "24014",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "A Johnson",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Ryan Evans, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.27097,
                        "lon": -79.94143
                    }
                },
                {
                    "facility": "Sentara Health",
                    "status": "RECRUITING",
                    "city": "Virginia Beach",
                    "state": "Virginia",
                    "zip": "23454",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "S Havert",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Samuel Steerman, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.85293,
                        "lon": -75.97799
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007676",
                    "term": "Kidney Failure, Chronic"
                },
                {
                    "id": "D000001164",
                    "term": "Arteriovenous Fistula"
                },
                {
                    "id": "D000005402",
                    "term": "Fistula"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000020763",
                    "term": "Pathological Conditions, Anatomical"
                },
                {
                    "id": "D000051436",
                    "term": "Renal Insufficiency, Chronic"
                },
                {
                    "id": "D000051437",
                    "term": "Renal Insufficiency"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000001165",
                    "term": "Arteriovenous Malformations"
                },
                {
                    "id": "D000054079",
                    "term": "Vascular Malformations"
                },
                {
                    "id": "D000018376",
                    "term": "Cardiovascular Abnormalities"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000016157",
                    "term": "Vascular Fistula"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000000013",
                    "term": "Congenital Abnormalities"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4472",
                    "name": "Arteriovenous Fistula",
                    "asFound": "Arteriovenous Fistula",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8532",
                    "name": "Fistula",
                    "asFound": "Fistula",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10699",
                    "name": "Kidney Failure, Chronic",
                    "asFound": "End Stage Renal Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "relevance": "LOW"
                },
                {
                    "id": "M26718",
                    "name": "Renal Insufficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22519",
                    "name": "Pathological Conditions, Anatomical",
                    "relevance": "LOW"
                },
                {
                    "id": "M26717",
                    "name": "Renal Insufficiency, Chronic",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M12",
                    "name": "Congenital Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M4473",
                    "name": "Arteriovenous Malformations",
                    "relevance": "LOW"
                },
                {
                    "id": "M27558",
                    "name": "Vascular Malformations",
                    "relevance": "LOW"
                },
                {
                    "id": "M20503",
                    "name": "Cardiovascular Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M18619",
                    "name": "Vascular Fistula",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}